Product Information
ESLICARBAZEPINE 400 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $2.9331 per EA under NDC 31722042930. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
400 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722042930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESLICARBAZEPINE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA211186On Market Since
8/3/2023
Pharmacological Classes
Price Statistics
The NADAC for ESLICARBAZEPINE 400 MG TABLET has been published 45 times since Aug 20, 2025, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9331 per EA |
|---|---|
| All-time high | $4.7606 (Sep 10, 2025) |
| All-time low | $2.9331 (Jun 17, 2026) |
| 52-week high | $4.7606 |
| 52-week low | $2.9331 |
| Median price | $3.2354 |
| Average price | $3.5618 |
| Largest weekly change | -10.5% (Nov 19, 2025) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESLICARBAZEPINE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESLICARBAZEPINE 400 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $2.9331 per EA (NDC 31722042930), effective Jun 24, 2026.
How has the price of ESLICARBAZEPINE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESLICARBAZEPINE 400 MG TABLET has declined 38.4%. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for ESLICARBAZEPINE 400 MG TABLET?
Since Aug 20, 2025, the NADAC for ESLICARBAZEPINE 400 MG TABLET has ranged from a low of $2.9331 (Jun 17, 2026) to a high of $4.7606 (Sep 10, 2025), with a median of $3.2354 per EA.
Are there cheaper alternatives to ESLICARBAZEPINE 400 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ESLICARBAZEPINE 400 MG TABLET, but none are currently priced below it.
Who manufactures ESLICARBAZEPINE 400 MG TABLET?
ESLICARBAZEPINE 400 MG TABLET (NDC 31722042930) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification